[Results show that OPN is not valuable as a clinical marker for monitoring the treatment response in multiple myeloma patients because of inconsistency in its levels in multiple myeloma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations inferred from text-mining the literature.
DisGeNET evidence - LITERATURE